You are cordially invited by your Bristol Myers Squibb representative to attend a presentation that will focus on: Reduction in the risk of stroke/SE in patients with nonvalvular atrial fibrillation (NVAF) in 1) a DOAC vs VKA randomized clinical trial 2) a DOAC vs DOAC real-world database analysis in Medicare beneficiaries published in JAMA (2021)

When & Where
Tuesday, September 19, 2023 at 6:30 PM – PST

Private Dining Room
Spencer’s For Steak and Chops
322 N Spokane Falls Ct
Spokane, Washington 99201

Program Faculty
Erik Kellison, PharmD, AACC, BCPS, BCACP, BCCP, OMT-HF
Medical Science Liaison Cardiovascular
Bristol Myers Squibb

RSVP
Register online: https://myattendeeresource.com/BMS/230919-BMS-90960
Email: Tori Nelson, tori.nelson@bms.com
Call: 1-866-326-7600 during the hours of 8:30 am to 5:00 pm EST, Monday–Friday, and refer to meeting ID 230919-BMS-90960

View Program Flyer: https://spokanepharmacy.org/wp-content/uploads/2023/08/nvaf-spokane-eric.pdf

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.